Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 3 1

Status

Recruiting 5

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 2Breast 1

Conditions

Colorectal Neoplasms 14Rectal Neoplasms 5Neoplasm Metastasis 5Cholangiocarcinoma 4Stomach Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Biliary Tract Neoplasms 3Adenocarcinoma Of Esophagus 3Ovarian Neoplasms 2Neoplasms 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Esophageal Neoplasms 2Recurrence 1Pathologic Complete Response 1Lung Neoplasms 1Gastroesophageal Adenocarcinoma 1Endometrial Neoplasms 1Disease Progression 1Central Nervous System Neoplasms 1Carcinoma, Basal Cell 1Breast Neoplasms 1Bile Duct Neoplasms 1Adenocarcinoma of the Lower Rectum 1Adenocarcinoma 1

Interventions

Specimen Handling 45pembrolizumab 41Biopsy 37Magnetic Resonance Spectroscopy 35Nivolumab 21Paclitaxel 20Gemcitabine 20Radiosurgery 19Carboplatin 19Irinotecan 14Ipilimumab 13Cisplatin 12Capecitabine 12130-nm albumin-bound paclitaxel 12Taxes 11Pemetrexed 11trastuzumab deruxtecan 10olaparib 10Leucovorin 10Fluorouracil 10Oxaliplatin 9Fulvestrant 9Cyclophosphamide 9Cetuximab 9durvalumab 8abemaciclib 8X-Rays 8Drug Therapy 8Bevacizumab 8palbociclib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Folfox protocol × 90 days × Clear all
NCT06846346 2026-04-28

GRACIE

UNICANCER

Phase 2 Recruiting
88 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT06475352 2026-04-23

FUDOSE

UNICANCER

Phase 2 Recruiting
400 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Colorectal Neoplasms

NCT06346197 2026-04-21

CIME

Centre Leon Berard

Phase 3 Recruiting
132 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

NCT06625775 2026-04-13

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Phase 1 Recruiting
392 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT06917079 2026-03-23

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Phase 1 Recruiting
387 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡